Testicular Cancer   

Bleomycin omitted due to asymptomatic decline in DLCO

Would surgical margins, evidence of angiolymphatic spread, number of lymph nodes removed during surgery inform your decision? 

If serum markers were normal, how strongly do you consider 1 cycle of BEP for embryonal predominant pathology? 

VIP can be considered, but given complex psychosocial issues and limited community cancer treatment resources, this question is being asked. 

NCCN guidelines state check at baseline and then as clinically indicated. Some other sources state, can check prior to each cycle of BEP?  What ...

Given persistent embryonal histology on RPLND, do you favor observation or TIP/VIP? What do you use to guide your decision?

Should treatment be based on current histology (rhabdomyosarcoma) or origin (germ cell)?

GI work up negative. NGS cancer type and isochromosome 12p ordered and pending. Pathology at RPLND was negative for cancer.  

There are conflicting reports of increased incidence of bleomycin-induced lung toxicity with G-CSF.

How do you assess risk of tumor lysis syndrome, and is hydration sufficient or should hypouricemic agents be used as well?

In a patient s/p orchiectomy and with pelvic lymphadenopathy, would you consider lymph node biopsy to confirm involvement by non-seminomatous germ cel...

Is any amount of teratoma or PNET an indication for surgery?